Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
N Engl J Med
.
2017 Mar 2;376(9):891-2.
doi: 10.1056/NEJMc1615712.
Authors
Steven P Marso
1
,
Anders G Holst
2
,
Tina Vilsbøll
3
Affiliations
1
Research Medical Center, Kansas City, MO.
[email protected]
2
Novo Nordisk, Søborg, Denmark
3
Center for Diabetes Research, Hellerup, Denmark
PMID:
28249135
DOI:
10.1056/NEJMc1615712
No abstract available
Publication types
Letter
Comment
MeSH terms
Cardiovascular Diseases
Diabetes Mellitus, Type 2*
Glycated Hemoglobin*
Humans
Substances
Glycated Hemoglobin A